Why the study?
Does treatment at a mega pPCI centre maintain quality of care and low mortality in patients with STEMI?
Cohort (n=2,066)
No
Does treatment at a mega pPCI centre maintain quality of care and low mortality in patients with STEMI?
Merging high-volume pPCI centres into a mega centre performing ~1,000 procedures annually can maintain excellent treatment delays and low 30-day mortality, challenging current maximum volume recommendations.
Mega-center consolidation may sustain STEMI metrics; leaves open whether volume caps warrant revision.
AIMS: The currently stated optimal catchment population for a pPCI centre is 300,000-1,100,000, resulting in 200-800 procedures/year. pPCI centres are increasing in number even within small geographic areas. We describe the organisation and quality of care after merging two high-volume centres, creating one mega centre serving 2.5 million inhabitants, and performing ~1,000 procedures/year. METHODS AND RESULTS: In this descriptive cohort study, we linked individual-level data from the national Central Population Register holding survival status with our in-hospital dedicated PCI database of baseline, organisational and procedural characteristics. Quality measures were treatment delays and 30-day all-cause mortality. In the three-year study period, 2,066 consecutive pPCIs were performed. After the fusion of the two centres, pPCI procedures increased by 102%, while door-to-balloon remained stable at 32 minutes. Up to 75.1% of patients were directly transferred by pre-hospital triage, of whom 82.7% had ECG-to-balloon <120 min, 92.6% had door-to-balloon <60 min. Thirty-day all-cause mortality remained low at 6.3%. CONCLUSIONS: This study challenges the stated maximal pPCI centre volume. The quality of a centre reflects governance, training, resources and pre-hospital triage, rather than catchment population and STEMI incidence, as long as a minimum volume is guaranteed. Resources can be utilised better by merging neighbouring centres, without negative effects on quality of care.
No takes yet. Share an insight, caveat, or question.
Schoos et al. (2015) conducted a cohort in ST-segment elevation myocardial infarction (n=2,066). Treatment at a merged mega primary PCI centre was evaluated on 30-day all-cause mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: